参考文献/References:
[1].Tuder RM,Archer SL,Dorfmüller P,et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension[J]. J Am Coll Cardiol,2013,62(25 Suppl):D4-D12.
[2].Condon DF,Nickel NP,Anderson R,et al. The 6th World Symposium on Pulmonary Hypertension:what’s old is new[J].?F1000Res,2019,?8:F1000 Faculty Rev-888.
[3].Hemnes AR,Kiely DG,Cockrill BA,et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute[J]. Pulm Circ,2015,5(3):435-465.
[4].Simonneau G,Gatzoulis MA,Adatia I,et al. Updated clinical classification of pulmonary hypertension[J]. J Am Coll Cardil,2013,62(25 suppl.):D34-D41.
[5].Sliwa K,van Hagen IM,Budts W,et al. Pulmonary hypertension and pregnancy outcomes:data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology[J]. Eur J Heart Fail,2016,18(9):1119-1128.
[6].Assad TR,Maron BA,Robbins IM,et al. Prognostic effect and longitudinal hemodynamic assessment of borderline pulmonary hypertension[J]. JAMA Cardiol,2017,2(12):1361-1368.
[7].Maron BA,Hess E,Maddox TM,et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort:insights from the veterans affairs clinical assessment,reporting,and tracking program[J]. Circulation,2016,133(13):1240-1248.
[8].Douschan P,Kovacs G,Avian A,et al.Mild elevation of pulmonary arterial pressure as a predictor of mortality[J]. Am J Respir Crit Care Med,2018,197(4):509-516.
[9].中华医学会呼吸病学分会肺栓塞与肺血管病组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组,等. 中国肺动脉高压诊断与治疗指南(2021版)[J]. 中华医学杂志,2021,101(1):11-51.
[10].Prins KW,Rose L,Archer SL,et al. Clinical determinants and prognostic implications of right ventricular dysfunction in pulmonary hypertension caused by chronic lung disease[J]. J Am Heart Assoc,2019,8(2):e011464.
[11].Lahm T,Crisostomo PR,Markel TA,et al. Selective estrogen receptor-α and estrogen receptor-β agonists rapidly decrease pulmonary artery vasoconstriction by a nitric oxide-dependent mechanism[J]. Am J Physiol Regul Integr Comp Physiol,2008,295(5):R1486-R1493.
[12].Jones RD,English KM,Pugh PJ,et al. Pulmonary vasodilatory action of testosterone:evidence of a calcium antagonistic action[J]. J Cardiovasc Pharmacol,2002,39(6):814-823.
[13].Tofovic SP. Estrogens and development of pulmonary hypertension:interaction of estradiol metabolism and pulmonary vascular disease[J]. J Cardiovasc Pharmacol,2010,56(6):696-708.
[14].Kawut SM,Al-Naamani N,Agerstrand C,et al. Determinants of right ventricular ejection fraction in pulmonary arterial hypertension[J]. Chest,2009,135(3):752-759.
[15].Dempsie Y,MacRitchie NA,White K,et al. Dexfenflfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension[J]. Cardiovasc Res,2013,99(1):24-34.
[16].White K,Loughlin L,Maqbool Z,et al. Serotonin transporter,sex,and hypoxia:microarray analysis in the pulmonary arteries of mice identififies genes with relevance to human PAH[J]. Physiol Genomics,2011,43(8):417-437.
[17].Oka M,Karoor V,Homma N,et al. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension[J]. Cardiovasc Res,2007,74(3):377-387.
[18].Xu DQ,Luo Y,Liu Y,et al. Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats[J]. Respir Res,2010,11(1):182.
[19].H?nicke U,Albrecht S,Schr?tter H,et al. Prolactin and its 16-kDa N-terminal fragment:are higher in patients with precapillary pulmonary hypertension than in a healthy control group[J]. Tex Heart Inst J,2012,39(1):44-50.
[20].Hernández-Díaz S,van Marter LJ,Werler MM,et al. Risk factors for persistent pulmonary hypertension of the new-born[J]. Pediatrics,2007,120(2):e272-e282.
[21].Lahm T,Patel KM,Crisostomo PR,et al. Endogenous estrogen attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction:the effects of sex and menstrual cycle[J]. Am J Physiol Endocrinol Metab,2007,293(3):E865-E871.
[22].Murphy E. Estrogen signaling and cardiovascular disease[J]. Circ Res,2011,109(6):687-696.
[23].Ventetuolo CE,Ouyang P,Bluemke DA,et al. Sex hormones are associated with right ventricular structure and function:the MESA-right ventricle study[J]. Am J Respir Crit Care Med,2011,183(5):659-667.
[24].Umar S,Iorga A,Matori H,et al. Estrogen rescues preexisting severe pulmonary hypertension in rats[J]. Am J Respir Crit Care Med,2011,184(6):715-723.
[25].Lahm T,Albrecht M,Fisher AJ,et al. 17β-estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects[J]. Am J Respir Crit Care Med,2012,185(9):965-980.
[26].Cheng TC,Philip JL,Tabima D,et al. Estrogen receptor alpha prevents right ventricular diastolic dysfunction and fibrosis in female rats[J]. Am J Physiol Heart Circ Physiol,2020,319(6):H1459-H1473.
[27].Alzoubi A,Toba M,Abe K,et al. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension[J]. Am J Physiol Heart Circ Physiol,2013,304(12):H1708-H1718.
[28].Dumas-de La Roque E,Bellance N,et al. Dehydroepiandrosterone reverses chronic hypoxia/reoxygenation-induced right ventricular dysfunction in rats[J]. Eur Respir J,2012,40(6):1420-1429.
[29].Hemnes AR,Maynard KB,Champion HC,et al. Testosterone negatively regulates right ventricular load stress responses in mice[J]. Pulm Circ,2012,2(3):352-358.
[30].Hester J,Ventetuolo C,Lahm T. Sex,Gender,and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure[J]. Compr Physiol,2019,10(1):125-170.
相似文献/References:
[1]孟晓冬,单福祥,综述,等.肺动脉高压治疗进展[J].心血管病学进展,2016,(3):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
MENG Xiaodong,SHAN Fuxiang,WANG Yanhui.Advances in Research of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2016,(7):319.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.028]
[2]张艺韬,综述,曾伟杰,等.左心疾病相关肺动脉高压流行病学[J].心血管病学进展,2016,(4):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
ZHANG Yitao,ZENG Weijie,CHENG Kanglin.Epidemiology of Pulmonary Hypertension due to Left Heart Disease[J].Advances in Cardiovascular Diseases,2016,(7):333.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.002]
[3]汪汉,刘英杰,王燕凤.长链非编码RNA与肺动脉高压[J].心血管病学进展,2019,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
WANG Han,LIU Yingjie,WANG Yanfeng.Long Non-coding RNA in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):898.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.015]
[4]汪汉 邓祁 刘英杰.系统性红斑狼疮相关肺动脉高压的诊断、治疗及预后[J].心血管病学进展,2019,(8):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
WANG Han,DENG Qi,LIU Yingjie.Diagnosis,Treatment and Prognosis of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus[J].Advances in Cardiovascular Diseases,2019,(7):1142.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.018]
[5]段宇 贾静 步睿 李涛 韦宏.急性伊洛前列素吸入对肺动脉高压患者右心室功能的影响[J].心血管病学进展,2019,(9):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
DUAN Yu,JIA Jing,BU Rui,et al.The Effect of Acute Iloprost Inhalation on Right Ventricular Function in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):1319.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.034]
[6]查玉杰 何庆.肺动脉高压发生发展中的相关因子[J].心血管病学进展,2020,(2):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
ZHA YujieHE Qing.The Relevant Factors in the Development of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(7):192.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.024]
[7]朱珊英,朱国斌.肺动脉高压发病机制新进展[J].心血管病学进展,2020,(3):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
ZHU Shanying,ZHU Guobin.Pathogenesis of Pulmonary Hypertension[J].Advances in Cardiovascular Diseases,2020,(7):292.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.019]
[8]韩柯,孟祥光,赵育洁.趋化因子及其受体在肺动脉高压中的研究进展[J].心血管病学进展,2020,(3):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
HAN Ke,MENG Xiangguang,ZHAO Yujie.Chemokines and Their Receptors in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(7):296.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.020]
[9]刘超 曲杰 王明娟 徐倩 范彦芳 周晓慧 单伟超.肺动脉高压对扩张型心肌病预后的影响[J].心血管病学进展,2020,(4):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
LIU ChaoQU JieWANG MingjuanXU QianFAN YanfangZHOU XiaohuiSAN Weichao.The Effect of Pulmonary Hypertension on the Prognosis of Dilated Cardiomyopathy[J].Advances in Cardiovascular Diseases,2020,(7):424.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.023]
[10]向杰 刘明鑫 张伟 黄从新.基于生物信息学分析探究肺动脉高压关键基因和通路[J].心血管病学进展,2020,(4):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]
Xiang JieLiu MingxinZhang WeiHuang Congxin.Bioinformatics Analysis of Key Genes and Pathways in Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2020,(7):428.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.024]